A5022999007- Advanced Radiotherapy Techniques
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Head and Neck Cancer Studies
- Oral health in cancer treatment
- Effects of Radiation Exposure
- Radiomics and Machine Learning in Medical Imaging
- Lung Cancer Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Radiation Therapy and Dosimetry
- Radiation Dose and Imaging
- Medical Imaging Techniques and Applications
- Colorectal Cancer Surgical Treatments
- Head and Neck Surgical Oncology
- Bladder and Urothelial Cancer Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Statistical Methods in Clinical Trials
- Colorectal and Anal Carcinomas
- Urologic and reproductive health conditions
- Breast Cancer Treatment Studies
- Breast Implant and Reconstruction
- Lung Cancer Treatments and Mutations
- Voice and Speech Disorders
- Multiple and Secondary Primary Cancers
- Advanced X-ray and CT Imaging
Erasmus MC Cancer Institute
2017-2025
Erasmus MC
2019-2025
The Netherlands Cancer Institute
2011-2022
University of California, Los Angeles
2022
Erasmus University Rotterdam
2019
Oncode Institute
2001-2016
University Hospital Augsburg
2016
Hospital de Sant Pau
2015
Radiotherapeutisch Instituut Friesland
2006
Haga Hospital
2006
Purpose To determine whether a dose of 78 Gy improves outcome compared with conventional 68 for prostate cancer patients treated three-dimensional conformal radiotherapy. Patients and Methods Between June 1997 February 2003, stage T1b-4 were enrolled onto multicenter randomized trial comparing Gy. stratified by institution, age, (neo)adjuvant hormonal therapy (HT), treatment group. Four groups (with specific radiation volumes) defined based on the probability seminal vesicle involvement. The...
To assess the impact of intensity modulated radiotherapy (IMRT) versus conventional radiation on late xerostomia and Quality Life aspects in head neck cancer patients. PATIENTS AND NETHODS: Questionnaires rest during meals were sent to all patients treated between January 1999 December 2003 with a T1-4, N0-2 M0 cancer, parotid gland sparing IMRT or bilateral irradiation dose at least 60 Gy, who progression free had no disseminated disease (n = 192). Overall response was 85% 163); 97% group...